Next Article in Journal
Difference in Methylation and Expression of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Mild Cognitive Impairment
Next Article in Special Issue
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review
Previous Article in Journal
Sex-Specific Patterns of Diaphragm Phospholipid Content and Remodeling during Aging and in a Model of SELENON-Related Myopathy
Previous Article in Special Issue
Evaluation of the Role of Faecal Calprotectin in the Management of Psoriatic Patients under Treatment with Biologic Drugs
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 11
Issue 2
10.3390/biomedicines11020236
Review Report
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Review
Peer-Review Record

New Indications of Biological Drugs in Allergic and Immunological Disorders: Beyond Asthma, Urticaria, and Atopic Dermatitis

Biomedicines 2023, 11(2), 236; https://doi.org/10.3390/biomedicines11020236
by Daniele Russo, Paola Di Filippo *, Sabrina Di Pillo, Francesco Chiarelli and Marina Attanasi
Reviewer 1: Anonymous
Reviewer 2:
Kinga Lis
Biomedicines 2023, 11(2), 236; https://doi.org/10.3390/biomedicines11020236
Submission received: 8 December 2022 / Revised: 13 January 2023 / Accepted: 15 January 2023 / Published: 17 January 2023
(This article belongs to the Special Issue Immune-Mediated Skin Diseases: From Pathophysiology to Novel Therapeutic Approaches 2.0)

Round 1

Reviewer 1 Report

1.Psoriasis is not an allergic disease, and away from the concept of this review regarding allergic diseases (all other diseases in this review are allergy-related), thus should not be discussed in this review and should be deleted.

2.Table 1

AIT= allergen immunotherapy is not the name of disease, so it is not correct to put this term on the present position in this table.

Where (in which countries) the Approval is obtained should be described for each therapy. Europe? USA?  

Author Response

We thank the reviewer for his precious advise. As suggested, we have deleted psoriasis from the text by focusing exclusively on allergic pathologies. We also modified the table as requested.

Reviewer 2 Report

The manuscript contains interesting information regarding the biological treatment of various clinical manifestations of allergic diseases. Authors analyzed the available studies from the last years (mainly up to 10 years ago). The analysis is clearly divided by test units. In my opinion, this arrangement of the text increases the clarity of the study. The analysis is performed correctly. I believe that the manuscript can be published in its present form. However, I advise you to re-analyze the text in terms of linguistic correctness in order to remove typical minor stylistic and typographical errors. I have no other comments.

Author Response

We really thank the reviewer for his comments and his precious suggestions. We have re-analyzed the text and removed stylistic and typographical errors as requested.

Back to TopTop